» Articles » PMID: 27856640

G Protein-coupled Receptors (GPCRs) That Signal Via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the Phosphatidylinositol 3-kinase (PI3K)/AKT Pathway

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2016 Nov 19
PMID 27856640
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

G protein-coupled receptors (GPCRs) activate PI3K/v-AKT thymoma viral oncoprotein (AKT) to regulate many cellular functions that promote cell survival, proliferation, and growth. However, the mechanism by which GPCRs activate PI3K/AKT remains poorly understood. We used ovarian preantral granulosa cells (GCs) to elucidate the mechanism by which the GPCR agonist FSH via PKA activates the PI3K/AKT cascade. Insulin-like growth factor 1 (IGF1) is secreted in an autocrine/paracrine manner by GCs and activates the IGF1 receptor (IGF1R) but, in the absence of FSH, fails to stimulate YXXM phosphorylation of IRS1 (insulin receptor substrate 1) required for PI3K/AKT activation. We show that PKA directly phosphorylates the protein phosphatase 1 (PP1) regulatory subunit myosin phosphatase targeting subunit 1 (MYPT1) to activate PP1 associated with the IGF1R-IRS1 complex. Activated PP1 is sufficient to dephosphorylate at least four IRS1 Ser residues, Ser, Ser, Ser, and Ser, and promotes IRS1 YXXM phosphorylation by the IGF1R to activate the PI3K/AKT cascade. Additional experiments indicate that this mechanism also occurs in breast cancer, thyroid, and preovulatory granulosa cells, suggesting that the PKA-dependent dephosphorylation of IRS1 Ser/Thr residues is a conserved mechanism by which GPCRs signal to activate the PI3K/AKT pathway downstream of the IGF1R.

Citing Articles

The coagulation and tumor system are directly linked through the proteolysis and activation of epidermal growth factor receptor by thrombin.

Wang T, Shen Z, Yang L, Zhang X, Yu M, Yu S Oncogene. 2025; .

PMID: 39910317 DOI: 10.1038/s41388-025-03296-1.


Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications.

Hashemi M, Abolghasemi Fard A, Pakshad B, Asheghabadi P, Hosseinkhani A, Hosseini A Noncoding RNA Res. 2024; 11:1-21.

PMID: 39720352 PMC: 11665378. DOI: 10.1016/j.ncrna.2024.11.006.


The signaling landscape of insulin-like growth factor 1.

Khan M, Zugaza J, Torres Aleman I J Biol Chem. 2024; 301(1):108047.

PMID: 39638246 PMC: 11748690. DOI: 10.1016/j.jbc.2024.108047.


Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Pathway in Advanced Oestrogen-Receptor-Positive Breast Cancer.

Browne I, Okines A Cancers (Basel). 2024; 16(12).

PMID: 38927964 PMC: 11201395. DOI: 10.3390/cancers16122259.


Analysis of the Expression of in Patients with Hepatocellular Carcinoma and its Effect on the Phenotype of Hepatocellular Carcinoma Cells.

Mu R, Chang M, Feng C, Cui Y, Li T, Liu C Curr Genomics. 2024; 25(1):2-11.

PMID: 38544826 PMC: 10964084. DOI: 10.2174/0113892029273682240111052317.


References
1.
Chen X, Zheng Y, Shen Y . Natural products with maleic anhydride structure: nonadrides, tautomycin, chaetomellic anhydride, and other compounds. Chem Rev. 2007; 107(5):1777-830. DOI: 10.1021/cr050029r. View

2.
Kroeze W, Sheffler D, Roth B . G-protein-coupled receptors at a glance. J Cell Sci. 2003; 116(Pt 24):4867-9. DOI: 10.1242/jcs.00902. View

3.
Hsueh A, Kawamura K, Cheng Y, Fauser B . Intraovarian control of early folliculogenesis. Endocr Rev. 2014; 36(1):1-24. PMC: 4309737. DOI: 10.1210/er.2014-1020. View

4.
Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B . The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010; 11(5):329-41. DOI: 10.1038/nrm2882. View

5.
Kinoshita E, Kinoshita-Kikuta E, Koike T . Phos-tag SDS-PAGE systems for phosphorylation profiling of proteins with a wide range of molecular masses under neutral pH conditions. Proteomics. 2011; 12(2):192-202. DOI: 10.1002/pmic.201100524. View